Stay updated with breaking news from Refractory Complex Partial Seizures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
InvaGen Pharmaceuticals Inc., affiliated to Cipla Ltd., is recalling one lot of Vigabatrin for Oral Solution, USP, citing leakage issues, according to the U.S Food and Drug Administration or FDA.
Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level.
/PRNewswire/ -- Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for...
Vigabatrin Market | Amneal Pharma, Benta Pharma Industries, Cipla
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Vigabatrin for Oral Solution USP, 500 mg.